Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
GlaxoSmithKline plc
Index- P/E17.20 EPS (ttm)2.69 Insider Own- Shs Outstand2.43B Perf Week0.00%
Market Cap112.43B Forward P/E15.13 EPS next Y3.06 Insider Trans- Shs Float2.39B Perf Month3.40%
Income6.55B PEG5.73 EPS next Q- Inst Own10.60% Short Float0.22% Perf Quarter-3.62%
Sales37.14B P/S3.03 EPS this Y22.50% Inst Trans-5.00% Short Ratio1.07 Perf Half Y-12.56%
Book/sh3.31 P/B13.98 EPS next Y0.49% ROA10.40% Target Price50.00 Perf Year-7.72%
Cash/sh2.71 P/C17.08 EPS next 5Y3.00% ROE67.60% 52W Range41.34 - 54.46 Perf YTD-8.70%
Dividend2.45 P/FCF- EPS past 5Y4.70% ROI24.90% 52W High-14.62% Beta0.65
Dividend %5.29% Quick Ratio0.70 Sales past 5Y1.70% Gross Margin69.40% 52W Low12.47% ATR0.45
Employees99451 Current Ratio1.00 Sales Q/Q-10.00% Oper. Margin24.30% RSI (14)64.85 Volatility0.81% 0.78%
OptionableYes Debt/Eq3.76 EPS Q/Q-58.10% Profit Margin17.80% Rel Volume0.41 Prev Close46.28
ShortableYes LT Debt/Eq2.70 EarningsFeb 03 Payout91.10% Avg Volume4.87M Price46.50
Recom2.50 SMA202.15% SMA503.16% SMA200-6.25% Volume1,998,504 Change0.48%
Aug-08-14Reiterated Argus Buy $65 → $55
Apr-23-14Upgrade Argus Hold → Buy
May-28-13Upgrade Deutsche Bank Hold → Buy
Jan-11-11Upgrade Jefferies Hold → Buy
Jun-02-10Upgrade Jefferies Hold → Buy
Feb-16-10Upgrade JP Morgan Underweight → Neutral $26
Jan-13-10Downgrade Credit Suisse Outperform → Underperform
Nov-24-09Initiated Leerink Swann Mkt Perform
Nov-16-09Initiated Deutsche Securities Hold
Nov-12-09Initiated Barclays Capital Equal Weight
Oct-23-09Downgrade Jefferies & Co Buy → Hold
Mar-17-09Initiated Credit Suisse Outperform
Jan-26-09Initiated Jefferies & Co Buy
Nov-14-08Downgrade UBS Buy → Neutral
Apr-18-08Downgrade JP Morgan Neutral → Underweight
Feb-11-08Upgrade UBS Neutral → Buy
Feb-01-08Upgrade HSBC Securities Underweight → Neutral
Oct-24-07Initiated Bernstein Mkt Perform
Sep-06-07Initiated UBS Neutral
Jul-25-07Downgrade Bear Stearns Peer Perform → Underperform
Nov-26-14 02:24PM  Novartis to Divest Nicotine Patch Habitrol at The Wall Street Journal
12:30PM  AstraZeneca's (AZN) Respiratory Drug Approved in the EU Zacks
Nov-24-14 03:57PM  Merck, Iowa firm sign Ebola vaccine licensing deal AP
10:57AM  Buying Glaxo's Biotech Stock Throwbacks Proves Profitable Yahoo Finance Blogs
10:22AM  BioMarin Buys Prosensa Backs Up Troubled Drug at Investor's Business Daily
03:51AM  GSK shareholders to vote on Novartis deal on Dec. 18 Reuters
Nov-19-14 12:24PM  Sanofi's case for experimental drugs in pipeline at CNBC
Nov-18-14 07:35PM  The Top Performing And Yielding Dividend Funds at Investor's Business Daily
01:04PM  Good News From A Failed Digital Health Randomized Clinical Trial: It Was Performed at Forbes
Nov-14-14 03:00AM  Europe shares open higher with positive GDP figures CNBC
Nov-13-14 08:31AM  Is A Boston University Professor's Plan For Lower Drug Costs Viable? at Forbes
Nov-12-14 03:14PM  Ebola To Have A Global Burden Of $5.9 Billion By End Of 2016 at Forbes
Nov-11-14 11:52AM  Aegerion to Acquire Myalept, Boost Portfolio - Shares Up Zacks
11:33AM  Insys Q3 Beats Estimates, Helping Stock Rebound at Investor's Business Daily
Nov-10-14 08:34AM  The Inaccurate And Unfair WHO Attack On Pharma Ebola Efforts at Forbes
Nov-06-14 12:01PM  FTSE ends higher after ECB hints at stimulus at MarketWatch
Nov-05-14 08:15AM  Ebola Is A Symptom Of Our Compounding Failures at Forbes
Nov-04-14 11:02AM  Bill Gates-Backed Group Weighs Funding for Ebola Vaccine at Bloomberg
Oct-29-14 08:59AM  Dear Sanofi: Firing CEO Chris Viehbacher Is A Huge Mistake at Forbes
Oct-28-14 09:37PM  After merger, where's Walgreen Boots Alliance headed? CNBC
03:31PM  In Ebola Crisis, New Vaccine Candidates Show Uncertain Promise at Forbes
10:07AM  Ebola: The making of a $1 billion drug at
06:12AM  Novartis' precision M&A plan: CEO CNBC
Oct-27-14 06:48PM  The Ebola Crisis In 3 Charts And 3 Articles at Forbes
01:38PM  Will Novartis (NVS) Disappoint in Q3 Earnings Season? Zacks
Oct-26-14 02:59PM  Drugmakers bet on Ebola vaccines, treatments at USA TODAY
Oct-24-14 09:51AM  J&J and Glaxo Ready to Collaborate for Ebola Vaccine Work Zacks
08:35AM  Glaxo Gains on Q3 Earnings Beat and Restructuring Plans Zacks
Oct-23-14 11:44PM  Head of GSK Ebola Vaccine Research: "Can We Even Consider Doing A Trial?" at Forbes
01:38PM  Drugmakers want indemnity CNBC
12:51AM  [$$] GlaxoSmithKline Unveils Cost-Saving Plan, Considers IPO of HIV Business at The Wall Street Journal
Oct-22-14 04:30PM  Stocks Erase Gains to End Lower Morningstar
11:57AM  Alibaba bounces back, Six Flags riding high and Glaxo to tackle Ebola Yahoo Finance
11:30AM  Stocks Move Higher Again After Earnings Morningstar
10:23AM  Glaxo Considers ViiV IPO to Capitalize on HIV-Drug Sales at Bloomberg
09:38AM  Europe shares fluctuate on ECB rumors; BAT falls at CNBC
09:14AM  GlaxoSmithKline moving forward with Ebola vaccine at Fortune
08:46AM  Why GlaxoSmithKline (GSK) Stock Is Up Today at TheStreet
07:55AM  [$$] Glaxo Third-Quarter Earnings Beat Expectations at The Wall Street Journal
07:48AM  GSK CEO and CFO Interviewed on 2014 Q3 Results PR Newswire
07:22AM  GSK revenue disappoints with 3% fall to $8.9B at CNBC
07:16AM  Glaxo Third-Quarter Profit Beat Estimates at Bloomberg
05:00AM  Learn How To Invest Defensively From This Hedge Fund Pro at Investopedia
01:50AM  Testing for Ebola Vaccines to Start Soon, W.H.O. Says at New York Times
Oct-21-14 07:29PM  Earnings set to take markets' center stage at CNBC
03:17PM  Trading Ebola CNBC
01:31PM  Vaccines, Medical Oxygen, and Helping the Ebola Crisis Accesswire
11:26AM  Glaxo Rising Star Connelly Under Pressure as Drugs Falter at Bloomberg
Oct-20-14 05:15PM  Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? Zacks
09:00AM  ViiV Healthcare Expands Program to Reduce HIV Disparities in Southern U.S. PR Newswire
08:09AM  The Zacks Analyst Blog Highlights: GlaxoSmithKline, NewLink Genetics, Allergan, Inovio Pharmaceuticals and BioCryst Pharmaceuticals Zacks
Oct-18-14 12:12PM  U.K.s Glaxo Working to Accelerate Treatment for Ebola Virus at Bloomberg
Oct-17-14 04:50PM  Next week's earnings: Tech takes center stage CNBC
01:35PM  Healthcare Stocks in Focus on Ebola Fears Zacks
Oct-16-14 08:53AM  CDC needs to get ahead of Ebola: Cramer CNBC
Oct-15-14 10:00AM  Ebola: Is the world ready for the next pandemic? at CNBC
Oct-10-14 04:52PM  AstraZeneca's Benralizumab Encourages in Phase II Study Zacks
01:03PM  GSK, REGN And SHPG, 3 Drugs Stocks Pushing The Industry Lower at TheStreet
Oct-09-14 02:38PM  Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear at Investor's Business Daily
02:18AM  Glaxo Agrees to Take 25% Stake in Aspen Pharmacare Japanese Unit at Bloomberg
Oct-07-14 05:10PM  Teva to Concentrate on Core Specialty Therapeutics Zacks
01:36PM  Flu Drug Study Sees Ties Between Pharm Cos and Researchers' Positive Findings at The Wall Street Journal
12:16PM  Fast-tracking an Ebola vaccine may prove too slow at CNBC
09:15AM  Obama: US working on Ebola screening CNBC
09:15AM  [video] Obama: US working on Ebola screening at CNBC
08:01AM  Battling Ebola CNBC
07:16AM  How prepared is US to contain Ebola? CNBC
07:16AM  [video] How prepared is US to contain Ebola? at CNBC
06:01AM  Dallas Ebola patient to get experimental drug CNBC
Oct-06-14 02:41PM  First Ebola case contracted outside West Africa: Report CNBC
02:41PM  [video] First Ebola case contracted outside West Africa: Report at CNBC
02:00PM  Ebola patient gets Chimerix's drug CNBC
02:00PM  [video] Ebola patient gets Chimerix's drug at CNBC
10:13AM  Dallas patient with Ebola in critical condition CNBC
10:13AM  [video] Dallas patient with Ebola in critical condition at CNBC
Oct-04-14 10:00AM  [video] What You Need to Know About Female Whistleblowers in the Workplace at TheStreet
Oct-03-14 11:59AM  [$$] Credit Suisse Chairman Rohner to Join GlaxoSmithKline Board at The Wall Street Journal
11:50AM  Prosensa (RNA) Extends Re-Dosing of Drisapersen into Europe Zacks
07:03AM  CDC tracking contacts to Texas Ebola patient CNBC
Oct-01-14 04:17PM  Ebola vaccine: Why it's taking so long to make one at CNBC
03:04PM  Getting Ebola treatments to market may take time at MarketWatch
02:21PM  Ebola stocks: Who's leading? CNBC
02:21PM  [video] Ebola stocks: Who's leading? at CNBC
02:20PM  Ebola-Related Pharma Stocks Soar On First U.S. Case at Investor's Business Daily
09:15AM  Hot Action in Ebola-Related Stocks at Fox Business
08:14AM  Is Your Doctor Being Paid By Pharma? That Could Be Good. at Forbes
Sep-30-14 07:40PM  US won't see an Ebola epidemic: Expert CNBC
Sep-26-14 08:24PM  Ebola Shot Turned Down by WHO Is Best Hope as Virus Rages at Bloomberg
03:07PM  Biotech's future: The government is key Yahoo Finance
05:30AM  Ebola Shot Turned Down by WHO Is Now Best Hope Bloomberg
Sep-25-14 04:07PM  World Health Leaders' Response When Offered Ebola Vaccine: We'll Get Back to You Bloomberg
01:29PM  [video] Drug Firms Redirect Sales Pitch to Hospitals at MarketWatch
12:51PM  Ebola Shot Turned Down by WHO Is Best Hope as Virus Rages at Bloomberg
06:02AM  [$$] Glaxo Names Hampton Chairman at The Wall Street Journal
04:38AM  R.B.S. Chairman to Step Down at New York Times
03:01AM  Glaxo Names RBSs Hampton as Chairman, Replacing Gent at Bloomberg
Sep-24-14 07:01PM  Biotech Firm Adaptimmune Attracts $104 Million Investment at New York Times
05:29PM  Gilead's New HIV Drug Key To Long-Term Strategy at Investor's Business Daily
04:17PM  Why GlaxoSmithKline (GSK) Stock Rose Today at TheStreet
11:25AM  Glaxo Said Planning to Name RBSs Hampton as Chairman at Bloomberg
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company provides pharmaceutical products in various therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also offers consumer health products in total wellness, oral care, nutritional, and skin health areas. The company's total wellness products comprise Panadol for the treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; and ENO Tums, a rapid relief antacid. Its oral care products include Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. The company's nutrition products comprise Horlicks and Maxinutrition for nutrition; and skin health products include Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. In addition, it provides prescription medicines; and paediatric and adult vaccines against various infectious diseases. The company has a strategic cancer immunotherapy collaboration with Adaptimmune Limited to develop and commercialize NY-ESO-1 clinical cancer program. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerAug 11Buy3912271.66172,651675,457,614,37130,748,723Aug 11 04:55 PM
GLAXOSMITHKLINE PLC10% OwnerMay 09Buy8544835.30317,7702,715,292,313,28130,576,072May 13 04:43 PM
GLAXOSMITHKLINE PLC10% OwnerApr 01Buy12.00103,7621,245,1441,989,598Apr 02 12:42 PM
GLAXOSMITHKLINE PLCFormer 10% OwnerFeb 19Buy14.0035,000490,0001,356,533Feb 20 06:56 PM
GLAXOSMITHKLINE PLC10% OwnerFeb 11Buy12850698.95342,2294,397,881,850,96030,258,302Feb 13 04:41 PM
GLAXOSMITHKLINE PLCFormer 10% ShareholderFeb 10Buy12.00143,7731,725,276143,773Feb 12 05:56 PM